Clinical Trial Update: A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

A Phase II clinical trial investigating SHR-3045 Injection for rheumatoid arthritis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• SHR-3045 Injection (SHR-3045)

Snippet

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd | Conditions: Moderate to Severe Active Rheumatoid Arthritis | Phase 2 | Status: RECRUITING